RESUMEN
Transplant professionals recognize that the long-term follow-up of living organ donors is a priority, yet there has been no implemented solution to this problem. This critical gap is essential, because the transplant field is now emphasizing living donation as a means to address the organ shortage. We detail our living donor initiative, which sets several priorities we recognize as fundamental to persons who have donated organs at our transplant center. This intervention attempts to mitigate the donor and center factors that are known to contribute to the lack of long-term follow-up. Beyond that, our goals are aimed at providing ongoing engagement, wellness, clinical data accrual, laboratory follow-up, and social support for our living donors, in continuity. Our ultimate goal is to nurture the development of local living donor community networks by providing social engagement for current and past donors, which also serves as a platform for greater population education on the societal importance of living donation. This initiative is based on joint recognition by our transplant team and our hospital leadership that supporting the long-term welfare of living donors is essential to accomplishing the goal of expanding living donor transplantation. The transplant team and hospital missions are aligned, and both contribute resources to the initiative.
Asunto(s)
Continuidad de la Atención al Paciente/normas , Atención a la Salud/normas , Donadores Vivos , Trasplante de Órganos , Calidad de Vida , Obtención de Tejidos y Órganos , Humanos , PronósticoRESUMEN
Living kidney donors are often excluded from the shared decision making and patient-centered models that are advocated in medical practice. Thresholds for acceptable risk vary between transplant centers, and between clinicians and donors. Although donor selection committees commonly focus on medical risks, potential donors also consider nonmedical risks and burdens, which may alter their assessment of an acceptable level of medical risk. Thus, transplant centers may encounter ethical tensions between nonmaleficence and respect for donor autonomy. A donor-centered model of risk assessment and risk reconciliation would integrate the donor's values and preferences in a shared decision about their eligibility to donate. This paper argues for shifting to a donor-centered model of risk assessment, and presents a research agenda to facilitate the greater participation of donors in their own evaluation and approval processes.
Asunto(s)
Toma de Decisiones , Consentimiento Informado/ética , Donadores Vivos/ética , Autonomía Personal , Medición de Riesgo/ética , Obtención de Tejidos y Órganos/ética , Selección de Donante , Ética Médica , Humanos , Selección de PacienteRESUMEN
New approaches to address the kidney scarcity in the United States are urgently needed. The greatest potential source of kidneys is from living donors. Proposals to offer financial incentives to increase living kidney donation rates remain highly controversial. Despite repeated calls for a pilot study to assess the impact of financial compensation on living kidney donation rates, many fear that financial incentives will exploit vulnerable individuals and cast the field of transplantation in a negative public light, ultimately reducing donation rates. This paper provides an ethical justification for conducting a pilot study of a federally regulated approach to providing financial incentives to living kidney donors, with the goal of assessing donors' perceptions.
Asunto(s)
Trasplante de Riñón/métodos , Donadores Vivos/ética , Motivación , Nefrectomía/economía , Insuficiencia Renal/cirugía , Obtención de Tejidos y Órganos/economía , Ética Médica , Humanos , Trasplante de Riñón/economía , Trasplante de Riñón/ética , Relaciones Médico-Paciente , Proyectos Piloto , Proyectos de Investigación , Recolección de Tejidos y Órganos/economía , Recolección de Tejidos y Órganos/ética , Obtención de Tejidos y Órganos/ética , Estados Unidos , Poblaciones VulnerablesRESUMEN
We sought to assess how written informed consent practices for candidate living kidney donors have changed over the last 5 years and to assess compliance with Centers for Medicare and Medicaid (CMS) and Organ Procurement and Transplantation Network (OPTN) regulations that took effect in 2007. We requested evaluation consent forms from US centers that performed >5 living kidney transplants during the prior year (n = 184). We received 148 consent forms; each was reviewed for information provided and inclusion of CMS- and OPTN-required elements. We found that nearly all transplant centers now obtain written consent for living kidney donor evaluation. However, most centers' evaluation consent forms do not include all CMS and OPTN requirements. Multiple items balancing donor and recipient interests and confidentiality were omitted. In addition, information about payment for routine follow-up care, complications related to surgery and other health problems following surgery were highly variable and frequently ambiguous. As centers revise their consent forms to address the 2013 OPTN policies, our findings may help them identify areas of potential deficiency. We propose that UNOS develop a uniform donor evaluation consent form to improve the clarity, consistency and efficiency of living donor consent.
Asunto(s)
Adhesión a Directriz/estadística & datos numéricos , Política de Salud , Consentimiento Informado/legislación & jurisprudencia , Trasplante de Riñón/ética , Donadores Vivos/ética , Guías de Práctica Clínica como Asunto , Obtención de Tejidos y Órganos/organización & administración , Formularios de Consentimiento , Selección de Donante , Estudios de Seguimiento , Humanos , Consentimiento Informado/ética , Trasplante de Riñón/psicología , Donadores Vivos/psicología , Medicare , Pronóstico , Estados UnidosRESUMEN
OBJECTIVES: To report the attitudes and opinions of subjects in US clinical trials about whether or not, and why, they should receive post-trial access (PTA) to the trial drug, care and information. DESIGN: Focus groups, short self-administered questionnaires. SETTING: Boston, Dallas, Detroit, Oklahoma City. PARTICIPANTS: Current and recent subjects in clinical trials, primarily for chronic diseases. RESULTS: 93 individuals participated in 10 focus groups. Many thought researchers, sponsors, health insurers and others share obligations to facilitate PTA to the trial drug, if it benefited the subject, or to a therapeutic equivalent. Some thought PTA obligations include providing transition care (referrals to non-trial physicians or other trials, limited follow-up, short-term drug supply) or care for long-term adverse events. Others held, in contrast, that there are no PTA obligations regarding drugs or care. However, there was agreement that former subjects should receive information (drug name, dosage received, market approval date, long-term adverse effects, trial results). Participants frequently appealed to health need, cost, relationships, reciprocity, free choice and sponsor self-interest to support their views. Many of their reasons overlapped with those commonly discussed by bioethicists. CONCLUSION: Many participants in US trials for chronic conditions thought there are obligations to facilitate PTA to the trial drug at a "fair" price; these views were less demanding than those of non-US subjects in other studies. However, our participants' views about informational obligations were broader than those of other subjects and many bioethicists. Our results suggest that the PTA debate should expand beyond the trial drug and aggregate results.
Asunto(s)
Ensayos Clínicos como Asunto/ética , Continuidad de la Atención al Paciente/ética , Accesibilidad a los Servicios de Salud/ética , Obligaciones Morales , Sujetos de Investigación/psicología , Adulto , Anciano , Ensayos Clínicos como Asunto/psicología , Femenino , Grupos Focales , Humanos , Masculino , Persona de Mediana Edad , Preparaciones Farmacéuticas/provisión & distribución , Encuestas y Cuestionarios , Estados Unidos , Adulto JovenAsunto(s)
Aclimatación , Mitocondrias Musculares , Músculos/enzimología , Temperatura , Animales , Moscas DomésticasRESUMEN
Several studies have suggested an association between the farm crisis of the 1980's and the increase in mental health problems in rural America. A stress hypothesis for alcoholism would indeed predict such an association. The study presented herein examines the rate of new referrals for treatment of alcohol abuse and/or dependence to state-funded agencies in Nebraska. Between mid-1978 and mid-1986, the rate of subjects seeking treatment grew steadily, paralleling an increase in both population and available treatment programs. Yet, the total number of farmers seeking treatment peaked around 1982 and declined steadily thereafter, outpacing any change in the total number of farmers in the state. Possible interpretations of these findings are discussed.
Asunto(s)
Enfermedades de los Trabajadores Agrícolas/psicología , Agricultura/economía , Alcoholismo/psicología , Estrés Psicológico/complicaciones , Adulto , Anciano , Enfermedades de los Trabajadores Agrícolas/rehabilitación , Alcoholismo/rehabilitación , Servicios Comunitarios de Salud Mental/economía , Control de Costos/tendencias , Femenino , Necesidades y Demandas de Servicios de Salud/economía , Humanos , Masculino , Persona de Mediana Edad , Nebraska , Derivación y Consulta/economíaRESUMEN
Personnel recruitment and retention is one of the most challenging facets of management. Despite turnover rates, identifying and retaining good employees should be foremost on any managerial agenda. An effective employee recruiting/relations program enhances the overall productivity of an operation by addressing concerns at staff level, often considered the core of activity. In this issue, we asked our respondents: What methods do you use to recruit and retain medical technologists?